CAR T-cell therapy- Paving the way for sensitized kidney transplant patients.
T. Jarmi, Y. Luo, R. M. Attieh, Y. Qie, M. E. Gadd, T. Hundal, S. Mao, H. S. Murthy, B. C. Taner, M. Kharfan-Dabaja, H. Qin
This paper explores using CAR T-cells targeting BAFF-R to treat sensitized kidney transplant patients, showing cytotoxicity against autologous B cells and paving the way for clinical trials.
bioRxiv · Aug 24, 2023Immunology